Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
630 participants
INTERVENTIONAL
2004-07-31
2007-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Development and Piloting of a Just-in-Time, Personalized HIV Prevention Intervention for Youth Experiencing Homelessness and Unstable Housing
NCT03911024
Transitional Housing and HIV Health
NCT06829394
Enhanced Housing Placement Assistance
NCT03334825
Evaluation of an HIV Outreach Program
NCT00300183
HIV and STD Prevention for High-Risk, Inner-City, African American Youth
NCT00353405
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The Housing and Health Study is a multi-site, multi-agency research collaboration. This project is a unique collaboration between federal agencies (the Department of Housing and Urban Development and the Centers for Disease Control and Prevention), local government agencies, universities, and private not-for-profit organizations.
The goal of the project is to examine the impact of providing housing for people living with HIV who are homeless or at imminent risk of homelessness on their disease progression, their risks of transmitting HIV, and medical care access and utilization. A total of 630 people living with HIV from three study sites complete the baseline study sessions. Half the participants (n=315) are randomly assigned to each of the two study groups. Treatment group participants receive Housing and Health Study housing rental assistance, and comparison group participants receive assistance finding housing according to local standard practice.
At baseline, 6, 12, and 18 months after baseline, participants complete study questionnaires and provide blood specimens to test for CD4 and viral load. In addition, the cost effectiveness of the study will be investigated by examining the HIV-related costs averted by providing housing to persons at high risk for transmitting HIV.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Housing and Health Study housing rental assistance
Housing and Health Study housing rental assistance
Standard local practice housing assistance
Standard local practice housing assistance
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Housing and Health Study housing rental assistance
Standard local practice housing assistance
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* At least 18 years of age
* English or Spanish speaking
* Able to provide informed consent
* Able to participate in data collection protocol
* Categorized as low income (less than 80% of the Area Median Income)
* Homeless or at imminent risk of homelessness
* Able to provide information about identity
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
US Department of Housing and Urban Development
FED
RTI International
OTHER
Johns Hopkins University
OTHER
University of Pittsburgh
OTHER
Columbia University
OTHER
Centers for Disease Control and Prevention
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Centers for Disease Control and Prevention
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Daniel P Kidder, PhD
Role: PRINCIPAL_INVESTIGATOR
Centers for Disease Control and Prevention
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CDC-NCHSTP-4015
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.